Gossamer Bio, Inc. Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Gossamer Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • Gossamer Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$33.9M, a 16.2% increase year-over-year.
  • Gossamer Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$72.8M, a 61.5% increase year-over-year.
  • Gossamer Bio, Inc. annual Operating Income (Loss) for 2023 was -$184M, a 15.9% increase from 2022.
  • Gossamer Bio, Inc. annual Operating Income (Loss) for 2022 was -$219M, a 1.14% decline from 2021.
  • Gossamer Bio, Inc. annual Operating Income (Loss) for 2021 was -$216M, a 7.62% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$184M +$34.8M +15.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 -$219M -$2.47M -1.14% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$216M +$17.8M +7.62% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 -$234M -$47.8M -25.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-17
2019 -$186M -$37.1M -24.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-03
2018 -$149M -$142M -2139% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$6.65M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.